Syquant Capital SAS’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Syquant Capital SAS’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,130	Closed	-$2.57M	–	11
2023 Q4	$2.57M	Buy	+8,130	New	+$1.58M	11.61%	4

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Syquant Capital SAS's KRTX Position: Q1 2024 in Review

Syquant Capital SAS sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 8,130 shares — an estimated $2.57M sold.

Syquant Capital SAS first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.57M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Syquant Capital SAS reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Syquant Capital SAS sold 8,130 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.57M.
Syquant Capital SAS first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Syquant Capital SAS's Karuna Therapeutics, Inc. Common Stock position peaked at $2.57M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Syquant Capital SAS's 13F filing for Q1 2024, filed 9 Apr 2024.